Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study-Reference-Cited by-同舟云学术

Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study

Published:2023-10 Issue:10 Volume:5 Page:e647-e656
ISSN:2589-7500
Container-title:The Lancet Digital Health
language:en
Short-container-title:The Lancet Digital Health

Author:

He Jianxing,Wang Bo,Tao Jinsheng,Liu Qin,Peng Minhua,Xiong Shan,Li Jianfu,Cheng Bo,Li Caichen,Jiang Shunjun,Qiu Xiangcheng,Yang Yang,Ye Zhujia,Zeng Fanrui,Zhang Jian,Liu Dan,Li Weimin,Chen Zhiwei,Zeng Qingsi,Fan Jian-Bing,Liang Wenhua

Publisher

Elsevier BV

Subject

Health Information Management,Decision Sciences (miscellaneous),Health Informatics,Medicine (miscellaneous)

Reference38 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Global patterns and trends in lung cancer incidence: a population-based study;Zhang;J Thorac Oncol,2021

3. Progress and prospects of early detection in lung cancer;Blandin Knight;Open Biol,2017

4. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives;Oudkerk;Nat Rev Clin Oncol,2021

5. Factors that influence physician decision making for indeterminate pulmonary nodules;Vachani;Ann Am Thorac Soc,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study;Lung Cancer;2024-09

2. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG);eClinicalMedicine;2024-09

3. Altruistic seagull optimization algorithm enables selection of radiomic features for predicting benign and malignant pulmonary nodules;Computers in Biology and Medicine;2024-09

4. Prediction and verification of benignancy and malignancy of pulmonary nodules based on inflammatory related biological markers;Heliyon;2024-08

5. Cost of lung cancer diagnosis: cost differences between national health system and private sector;Lung Cancer Management;2024-07-15